Merger

Recorded: 2011-10-26 Pages: 5

Assignor

CORUS PHARMA, INC.

Executed: 2006-12-22

Assignee

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404

Covered Property (1)

Inhalable Aztreonam Lysinate Formulation for Treatment and Prevention of Pulmonary Bacterial Infections

Patent: 8,841,286 →

Application: 13/245,705 →

Publication: US 2012/0251585

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.